Home NDC 70720-125 Xermelo
Product NDC 70720-125
11-digit product format 707200125
Labeler code 70720
Product ID 70720-125_ba59d050-c350-492f-a421-f4b64f6fc60e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name telotristat ethyl
Dosage form TABLET
Route ORAL
Labeler TerSera Therapeutics LLC
Application NDA208794
Marketing category NDA
Marketing start 2020-10-05
Substance TELOTRISTAT ETHYL
Active strength 250 mg/1
Pharmacologic classes Tryptophan Hydroxylase Inhibitor [EPC], Tryptophan Hydroxylase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208794-001 XERMELO TELOTRISTAT ETIPRATE EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28
Orange Book patents# Current patent rows page 1 of 1 · 5 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N208794-001 7553840 2027-12-11 Drug substance 2017-03-23 N208794-001 7968559 2027-12-11 U-1979 2017-03-23 N208794-001 8653094 2028-12-19 U-1979 2017-03-23 N208794-001 8193204 2031-02-27 Drug substance 2017-03-23 N208794-001 7709493 2031-02-28 U-1979 Drug substance 2017-03-23
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N208794-001 XERMELO EQ 250MG BASE TABLET / ORAL RLD, RS 2017-02-28 cb3db0bc1861…
Observed Orange Book patent history# Patent history page 1 of 6 · 205 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N208794-001 7553840 2027-12-11 Drug substance 2017-03-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208794-001 7968559 2027-12-11 U-1979 2017-03-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208794-001 8653094 2028-12-19 U-1979 2017-03-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208794-001 8193204 2031-02-27 Drug substance 2017-03-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208794-001 7709493 2031-02-28 U-1979 Drug substance 2017-03-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208794-001 7553840 2027-12-11 Drug substance 2017-03-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208794-001 7968559 2027-12-11 U-1979 2017-03-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208794-001 8653094 2028-12-19 U-1979 2017-03-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208794-001 8193204 2031-02-27 Drug substance 2017-03-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208794-001 7709493 2031-02-28 U-1979 Drug substance 2017-03-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208794-001 7553840 2027-12-11 Drug substance 2017-03-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208794-001 7968559 2027-12-11 U-1979 2017-03-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208794-001 8653094 2028-12-19 U-1979 2017-03-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208794-001 8193204 2031-02-27 Drug substance 2017-03-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208794-001 7709493 2031-02-28 U-1979 Drug substance 2017-03-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208794-001 7553840 2027-12-11 Drug substance 2017-03-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208794-001 7968559 2027-12-11 U-1979 2017-03-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208794-001 8653094 2028-12-19 U-1979 2017-03-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208794-001 8193204 2031-02-27 Drug substance 2017-03-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208794-001 7709493 2031-02-28 U-1979 Drug substance 2017-03-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208794-001 7553840 2027-12-11 Drug substance 2017-03-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208794-001 7968559 2027-12-11 U-1979 2017-03-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208794-001 8653094 2028-12-19 U-1979 2017-03-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208794-001 8193204 2031-02-27 Drug substance 2017-03-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208794-001 7709493 2031-02-28 U-1979 Drug substance 2017-03-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208794-001 7553840 2027-12-11 Drug substance 2017-03-23 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208794-001 7968559 2027-12-11 U-1979 2017-03-23 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208794-001 8653094 2028-12-19 U-1979 2017-03-23 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208794-001 8193204 2031-02-27 Drug substance 2017-03-23 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208794-001 7709493 2031-02-28 U-1979 Drug substance 2017-03-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208794-001 7553840 2027-12-11 Drug substance 2017-03-23 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208794-001 7968559 2027-12-11 U-1979 2017-03-23 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208794-001 8653094 2028-12-19 U-1979 2017-03-23 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208794-001 8193204 2031-02-27 Drug substance 2017-03-23 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208794-001 7709493 2031-02-28 U-1979 Drug substance 2017-03-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208794-001 7553840 2027-12-11 Drug substance 2017-03-23 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208794-001 7968559 2027-12-11 U-1979 2017-03-23 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208794-001 8653094 2028-12-19 U-1979 2017-03-23 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208794-001 8193204 2031-02-27 Drug substance 2017-03-23 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208794-001 7709493 2031-02-28 U-1979 Drug substance 2017-03-23 5bbf6a4d5a75…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 53 observed states.
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base Xermelo
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TELOTRISTAT ETHYL 250 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 8G388563M7 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1872453 Internal RxNorm lookup 1872458 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70720-125-22 Xermelo 21 in 1 BLISTER PACK TABLET 21 5 70720-125-22 Xermelo 1 in 1 BOX TABLET 1 5 70720-125-85 Xermelo 4 in 1 CASE TABLET 4 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70720-125 XERMELO (TELOTRISTAT ETHYL) TABLET [TERSERA THERAPEUTICS LLC] 5 Current NDC, Legacy NDC, 3 package rows 20221005_a4ac9d62-887c-4c8f-b04d-a5f31cec7c86.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70720-125-22 70720012522 21 in 1 BLISTER PACK Historical 70720-125-85 70720012585 4 BOX in 1 CASE (70720-125-85) / 1 BLISTER PACK in 1 BOX (70720-125-22) / 21 TABLET in 1 BLISTER PACK 4 box 2021-10-01 0000-00-00 No No Current